Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction.
about
Increase in Red Blood Cell-Nitric Oxide Synthase Dependent Nitric Oxide Production during Red Blood Cell Aging in Health and Disease: A Study on Age Dependent Changes of Rheologic and Enzymatic Properties in Red Blood Cells.Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device.Circulating membrane-derived microvesicles in redox biology.Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Endothelial nitric oxide synthase in red blood cells: key to a new erythrocrine function?Central role of eNOS in the maintenance of endothelial homeostasisEndothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress.The Impact of Cocoa Flavanols on Cardiovascular Health.Update on the role of endothelial cells in trauma.Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.Placental Vesicles Carry Active Endothelial Nitric Oxide Synthase and Their Activity is Reduced in Preeclampsia.Identification of a soluble guanylate cyclase in RBCs: preserved activity in patients with coronary artery disease.Exercise intensity modulates the appearance of circulating microvesicles with proangiogenic potential upon endothelial cells.Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.Vitamin D suppresses oxidative stress-induced microparticle release by human umbilical vein endothelial cells.Extracellular Vesicles: A Novel Target for Exercise-Mediated Reductions in Type 2 Diabetes and Cardiovascular Disease Risk
P2860
Q35526318-1FC37333-2F3E-457A-AC66-6D0625D1548EQ35542818-362C386D-DACD-4511-B86F-48B9F9E73DBDQ35737756-0EE7B135-ADB5-439D-A86E-7CB81050EC44Q35968665-AF697338-4E12-492D-82DC-B03F677A6C44Q37254899-564717C4-44F0-4D92-BFD8-3DCA48C54B3DQ38185035-BABEA34A-43F3-4AFE-92B3-67466B4868AAQ38261420-079D316E-06F8-4B73-91F5-B6614F8409A9Q38688884-0D181FAD-F849-4973-B31E-27E408E00C34Q38882270-E93236EB-F69F-4D92-AADA-C60F5A2CDA26Q39413009-7C55EB88-0525-4F4B-8A7B-EDE5F55FD67EQ39540696-7BB24D61-DE73-4D67-B68E-7C0E99256A22Q40998130-F52BC5A3-3E1E-4211-B81C-F0FAB968C6E0Q47661369-5E175F53-BCD1-4D73-9E25-3A85E50A3875Q48255690-B1B392A6-C245-4CF0-BCE2-3A7282DB5C2BQ49741768-C2E29E58-D14F-47FE-B7F5-493DF0C73931Q51064693-5E3C3DE2-A23A-4B66-B6BC-A791A22EE0C7Q56358143-DFC9D305-523A-4E6C-A052-68F47836C7C9
P2860
Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Circulating microparticles car ...... with endothelial dysfunction.
@ast
Circulating microparticles car ...... with endothelial dysfunction.
@en
type
label
Circulating microparticles car ...... with endothelial dysfunction.
@ast
Circulating microparticles car ...... with endothelial dysfunction.
@en
prefLabel
Circulating microparticles car ...... with endothelial dysfunction.
@ast
Circulating microparticles car ...... with endothelial dysfunction.
@en
P2093
P2860
P356
P1476
Circulating microparticles car ...... s with endothelial dysfunction
@en
P2093
Christian Heiss
Claas Hundsdörfer
Klaus-Dietrich Kröncke
Nicolas Amabile
Patrick Horn
P2860
P304
P356
10.1161/JAHA.112.003764
P577
2012-12-31T00:00:00Z